New Research on Diabetes, Obesity, Heart Disease, Women's HealthIssues to Be Announced May 18 in Washington
Posted on: Tuesday, 17 May 2005, 09:00 CDT
News Advisory:
American Association of Clinical Endocrinologists 14th Annual Meeting and Clinical Congress.
Where: Marriott Wardman Park Hotel, Washington, D.C.
When: May 18 through May 22
Meeting Topics Include:
-- As competition in amateur and professional sports becomes more intense, so do the consequences. Sessions will include new information on performance-enhancing drugs and the impact exercise can have on the female reproductive system.
-- Diabetes and its complications are increasing faster in Hispanic and Latino populations than in any other ethnic group. Experts will address new strategies to treat diabetes, Insulin Resistance Syndrome, heart disease and more in Hispanics and Latinos. Special Spanish session on Saturday.
-- As obesity continues to take its toll on Americans' health, endocrinologists, the experts in metabolism and nutrition, are staged at the forefront to fight this epidemic. Doctors will discuss new therapies in obesity management, including diets, drugs, and surgery.
-- Emerging science has revolutionized the way women are treated for various conditions. The conference will include the new information on the diagnosis and treatment of menopause, heart disease, diabetes, pregnancy and other reproductive issues, osteoporosis, and more.
General sessions will be translated from English to Spanish or Italian.
Media Events:
State of Diabetes in America (May 18, 10 a.m.)
-- For the first time, AACE is releasing an in-depth, state- by- state evaluation of blood sugar control, which will provide a critical assessment of type 2 diabetes management across the United States.
-- Phone/Web access will be available.
Emerging Science: Exploring the Inner Dynamics of Diabetes (May 18, 12 p.m.)
-- Following the report highlighting the need for improved blood sugar control, AACE will host a lunchtime media "Teach In" designed to provide an in-depth review of the multi-dimensional pathophysiology of type 2 diabetes, current treatment approaches, and the next wave of emerging therapies.
-- Phone/Web access will be available.
Poster Session Press Preview (May 19, 9 a.m. to 9:45 a.m.)
-- Over 140 posters addressing the latest research in the field will be available to view before opening to general meeting attendees.
------
AACE is a professional medical organization with more than 5,200 members in the United States and 84 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity. For further information about AACE and the Annual Meeting, visit the AACE web site at http://www.aace.com.
http://www.usnewswire.com
Source: U.S. Newswire
Related Articles
- InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting
- InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
- Emerging Washington State Health Care Model Secures $7.5 Million in Venture Capital
- Teen Diabetes Reversed Through Obesity Surgery
- Obese Children Show Heart Disease Signs
- Mental Disorders Cost Most Among All Diseases in China
- Diabetes Cases Rise in the United States
- Diabetes: Facts, Tips and Trivia About the Disease
- Metabasis Therapeutics and Merck Announce Collaboration to Develop New Treatment for Diabetes, Hyperlipidemia and Obesity
- Meeting the Challenge of Epidemic Infectious Disease Outbreaks: An Agenda for Research
User Comments (0)

RSS Feeds